Want to see RNAZ full AI Analyst Report?
ETFs with TransCode Therapeutics (RNAZ) Exposure
The following ETFs maintain exposure to TransCode Therapeutics (RNAZ). ETF holdings data are updated periodically, based on the latest holdings the ETFs report, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.
1 ETF Hold TransCode Therapeutics (RNAZ)
| Symbol | ETF Name | AUM | Expense Ratio | % Weight in ETF | Market Value | % Weight in RNAZ |
|---|---|---|---|---|---|---|
| VXF | Vanguard Extended Market ETF | $30.86B | 0.05% | <0.01% | $11.00K | 0.04% |
| Symbol | % Weight in ETF | ETF Name | AUM | Expense Ratio | Market Value | % Weight in RNAZ |
|---|---|---|---|---|---|---|
| VXF | <0.01% | Vanguard Extended Market ETF | $30.86B | 0.05% | $11.00K | 0.04% |
Popular ETF Comparisons
RNAZ ETF Exposure FAQ
What ETFs hold TransCode Therapeutics stock?
TransCode Therapeutics (RNAZ) is currently held by 1 ETF in TipRanks’ ETF exposure database. The ETF(s) with exposure to RNAZ include Vanguard (VXF).
Which ETF has the largest exposure to RNAZ?
The ETF with the largest exposure to RNAZ is Vanguard (VXF), with approximately $11.00K in market value exposure.
How much RNAZ stock is held by ETFs?
ETFs currently hold approximately $11.00K worth of TransCode Therapeutics (RNAZ) stock, based on TipRanks’ ETF exposure data.
How often is ETF exposure data updated?
ETF exposure data is updated periodically based on the latest available ETF holdings and reporting data. Actual ETF positions may change between reporting periods.